Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk

Journal of the National Cancer Institute

Volumn 98, Issue 22, 2006, Pages 1607-1622

  Lewis, Sarah J ^a   Harbord, Roger M ^a   Harris, Ross ^a   Smith, George Davey ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

ANALYTICAL ERROR; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG ALCOHOL INTERACTION; EVIDENCE BASED MEDICINE; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PUBLISHING; RISK ASSESSMENT; SYSTEMATIC REVIEW;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYTOSINE; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HOMOZYGOTE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; THYMINE;

EID: 33751355257     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj440     Document Type: Article

References (85)

1. Bailey LB, Gregory JF. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement. J Nutr 1999;129:919-22.
2. Choi SW, Mason JB. Folate and carcinogenesis: An integrated scheme. J Nutr 2001;130:129-32.
3. Duthie SJ, Hawdon A. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J 1998;12:1491-7.
4. Zhang SM. Role of vitamins in the risk, prevention, and treatment of breast cancer. Curr Opin Obstet Gynecol 2004;16:19-25.
5. Prinz-Langenohl R, Fohr I, Pietrzik K. Beneficial role for folate in the prevention of colorectal and breast cancer. Eur J Nutr 2001;40:98-105.
6. Brekelmans CTM. Risk factors and risk reduction of breast and ovarian cancer. Curr Opin Obstet Gynecol 2003;15:63-8.
7. Brewster A, Helzlsouer K. Breast cancer epidemiology, prevention and early detection. Curr Opin Oncol 2001;13:420-5.
8. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
9. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.
10. Friso S, Choi SW, Girelli D, Mason JB, Dolnikowski GG, Bagley PJ, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A 2002;99:5606-11.
11. Davey Smith G, Ebrahim S. 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
12. Davey Smith G, Ebrahim S. Mendelian randomization: Prospects, potentials, and limitations. Int J Epidemiol 2004;33:30-42.
13. Chene G, Thompson SG. Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. Am J Epidemiol 1996;144:610.
14. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955;19:251-3.
15. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992;135:1301-9.
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
17. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
18. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
19. Graham S, Hellmann R, Marshall J, Freudenheim J, Vena J, Swanson M, et al. Nutritional epidemiology of postmenopausal breast cancer in western New York. Am J Epidemiol 1991;134:552-66.
20. Freudenheim JL, Marshall JR, Vena JE, Laughlin R, Brasure JR, Swanson MK, et al. Premenopausal breast cancer risk and intake of vegetables, fruits and related nutrients. J Natl Cancer Inst 1996;88:340-8.
21. Thorand B, Kohlmeier L, Simonsen N, Croghan C, Thamm M. Intake of fruits, vegetables, folic acid and related nutrients and risk of breast cancer in postmenopausal women. Public Health Nutr 1998;1:147-56.
22. Potischman N, Swanson CA, Coates RJ, Gammon MD, Brogan DR, Curtin J, et al. Intake of food groups and associated micronutrients in relation to risk of early-stage breast cancer. Int J Cancer 1999;82:315-21.
23. Ronco A, De Stefani E, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, Leborgne F. Vegetables, fruits, and related nutrients and risk of breast cancer: A case-control study in Uruguay. Nutr Cancer 1999;35:111-9.
24. Negri E, La Vecchia C, Franceschi S. Re: Dietary folate consumption and breast cancer risk. J Natl Cancer Inst 2000;92:1270-1.
25. Levi F, Pasche C, Lucchini F, La Vecchia C. Dietary intake of selected micronutrients and breast cancer risk. Int J Cancer 2001;91:260-3.
26. Shrubsole MJ, Jin F, Dai Q, Shu XO, Potter JD, Hebert JR, et al. Dietary folate intake and breast cancer risk: Results from the Shanghai Breast Cancer Study. Cancer Res 2001;61:7136-41.
27. Sharp L, Little J, Schofield AC, Pavlidou E, Cotton SC, Miedzybrodzka Z, et al. Folate and breast cancer: The role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett 2002;181:65-71.
28. Adzersen KH, Jess P, Freivogel KW, Gerhard I, Bastert G. Raw and cooked vegetables, fruits, selected micronutrients, and breast cancer risk: A case-control study in Germany. Nutr Cancer 2003;46:131-7.
29. Zhu K, Davidson NE, Hunter S, Yang X, Payne-Wilks K, Roland CL, et al. Methyl-group dietary intake and risk of breast cancer among African-American women: A case-control study by methylation status of the estrogen receptor alpha genes. Cancer Causes Control 2003;14:827-36.
30. Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, et al. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res 2005;65:1606-14.
31. Beilby J, Ingram D, Hahnel R, Rossi E. Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene. Eur J Cancer 2004; 40:1250-4.
32. Lajous M, Lazcano-Ponce E, Hernandez-Avila M, Willett W, Romieu I. Folate, vitamin B(6), and vitamin B(12) intake and the risk of breast cancer among Mexican women. Cancer Epidemiol Biomarkers Prev 2006;15:443-8.
33. Zhang S, Hunter DJ, Hankinson SE, Giovannucci EL, Rosner BA, Colditz GA, et al. A prospective study of folate intake and the risk of breast cancer. JAMA 1999;281:1632-7.
34. Rohan TE, Jain MG, Howe GR, Miller AB. Dietary folate consumption and breast cancer risk. J Natl Cancer Inst 2000;92:266-9.
35. Sellers TA, Kushi LH, Cerhan JR, Vierkant RA, Gapstur SM, Vachon CM, et al. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology 2001;12:420-8.
36. Feigelson HS, Jonas CR, Robertson AS, McCullough ML, Thun MJ, Calle EE. Alcohol, folate, methionine, and risk of incident breast cancer in the American Cancer Society Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 2003;12:161-4.
37. Cho E, Spiegelman D, Hunter DJ, Chen WY, Zhang SM, Colditz GA, et al. Premenopausal intakes of vitamins A, C, and E, folate, and carotenoids, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2003;12: 713-20.
38. Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN, Henderson BE. MTHFR polymorphisms, diet, HRT, and breast cancer risk: The Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev 2004;13:2071-77.
39. Baglietto L, English DR, Gertig DM, Hopper JL, Giles GG. Does dietary folate intake modify effect of alcohol consumption on breast cancer risk? Prospective cohort study. BMJ 2005;331:807.
40. Tjonneland A, Christensen J, Olsen A, Stripp C, Nissen SB, Overvad K, et al. Folate intake, alcohol and risk of breast cancer among postmenopausal women in Denmark. Eur J Clin Nutr 2006;60:280-6.
41. Wu K, Helzlsouer KJ, Comstock GW, Hoffman SC, Nadeau MR, Selhub J. A prospective study on folate, B12, and pyridoxal 5′-phosphate (B6) and breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:209-17.
42. Zhang SM, Willett WC, Selhub J, Hunter DJ, Giovannucci EL, Holmes MD, et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 2003;95:373-80.
43. Rossi E, Hung J, Beilby JP, Knuiman MW, Divitini ML, Bartholomew H. Folate levels and cancer morbidity and mortality: Prospective cohort study from Busselton, Western Australia. Ann Epidemiol 2006;16:206-12.
44. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, Johnson KA, Johnson C, Buys SS, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 2006;83:895-904.
45. Campbell IG, Baxter SW, Eccles DM, Choong DY. Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res 2002;4:R14.
46. Ergul E, Sazci A, Utkan Z, Canturk NZ. Polymorphisms in the MTHFR gene are associated with breast cancer. Tumour Biol 2003;24:286-90.
47. Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, et al. The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk. Breast Cancer Res Treat 2003;81:169-72.
48. Semenza JC, Delfino RJ, Ziogas A, Anton-Culver H. Breast cancer risk and methylenetetrahydrofolate reductase polymorphism. Breast Cancer Res Treat 2003;77:217-23.
49. Forsti A, Angelini S, Festa F, Sanyal S, Zhang Z, Grzybowska E, et al. Single nucleotide polymorphisms in breast cancer. Oncol Rep 2004;11:917-22.
50. Grieu F, Powell B, Beilby J, Iacopetta B. Methylenetetrahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype. Anticancer Res 2004;24:3215-20.
51. Lee SA, Kang D, Nishio H, Lee MJ, Kim DH, Han W, et al. Methylenetetrahydrofolate reductase polymorphism, diet and breast cancer in Korean women. Exp Mol Med 2004;36:116-21.
52. Lin WY, Chou YC, Wu MH, Huang HB, Jeng YL, Wu CC, et al. The MTHFR C677T polymorphism, estrogen exposure and breast cancer risk: A nested case-control study in Taiwan. Anticancer Res 2004;24:3863-8.
53. Qui J, Miao XP, Tan W, Yu CY, Liang G, Lu WF, et al. Association between genetic polymorphisms in methylenetetrahydrofolate reductase and risk of breast cancer. Chin J Oncol 2004;26:287-9.
54. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Hebert JR, et al. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: Results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2004;13:190-6.
55. Deligezer U, Akisik EE, Dalay N. Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population. In Vivo 2005;19:889-93.
56. Hekim N, Ergen A, Yaylim I, Yilmaz H, Zeybek U, Ozturk O, et al. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer. Cell Biochem Funct 2005. [Aug 30 Epub ahead of print].
57. Justenhoven C, Hamann U, Pierl CB, Rabstein S, Pesch B, Harth V, et al. One-carbon metabolism and breast cancer risk: No association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol Biomarkers Prev 2005;14:3015-8.
58. Kalemi TG, Lambropoulos AF, Gueorguiev M, Chrisafi S, Papazisis KT, Kotsis A. The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece. Cancer Lett 2005;222:57-65.
59. Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996;56:4862-4.
60. McGlynn KA, Wang L, Patrick-Acevedo NY, Strachan SD, Kruger WD. Methylenetetrahydrofolate reducatase, methionine synthase, folate, alcohol and breast cancer. The 91st Annual AACR meeting; 2000 Apr 1-5; San Francisco (CA). p. 92. American Association for Cancer Research, Philadelphia, PA.
61. Charles D, Ness AR, Campbell D, Davey Smith G, Hall MH. Taking folate in pregnancy and risk of maternal breast cancer. BMJ 2004;329:1375-6.
62. Bønaa KH. NORVIT: Randomised trial of homocysteine-lowering with B-vitamins for secondary prevention of cardiovascular disease after acute myocardial infarction. European Society of Cardiology Congress 2005 Sep 5; Stockholm. Stockholm (Sweden):EUropean Society of Cardiology. http//www.escardio.org/knowledge/onlinelearning/slides/ ESC_Congress_2005/BonaaFP1334.htm. [Last accessed: February 10, 2006.]
63. Sterne J, Davey Smith G. Sifting the evidence-what's wrong with significance tests? BMJ 2001;322:226-31.
64. Day NE, McKeown N, Wong MY, Welch A, Bingham S. Epidemiological assessment of diet: A comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol 2001;30:309-17.
65. Kristal AR, Peters U, Potter JD. Is it time to abandon the food frequency questionnaire? Cancer Epidemiol Biomarkers Prev 2005;14:2826-8.
66. Hao L, Ma J, Sampfer MJ, Ren A, Tian Y, Tang Y, et al. Geographical, seasonal and gender differences in folate status among Chinese adults. J Nutr 2003;133:3630-5.
67. Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, Rosner, et al. Food-based validation of a dietary questionnaire: The effects of week-to-week variation in food consumption. Int J Epidemiol 1989; 18:858-67.
68. Shu XO, Yang G, Jin F, Liu D, Kushi L, Wen W, et al. Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women's Health Study. Eur J Clin Nutr 2004;58:17-23.
69. Madigan MP, Troisi R, Potischman N, Brogan D, Gammon MD, Malone KE, et al. Characteristics of respondents and non-respondents from a case-control study of breast cancer in younger women. Int J Epidemiol 2000;29:793-8.
70. Mannisto S, Pietinen P, Virtanen M, Kataja V, Uusitupa M. Diet and the risk of breast cancer in a case-control study: Does the threat of disease have an influence on recall bias? J Clin Epidemiol 1999;52:429-39.
71. Halsted CH, Villanueva JA, Devlin AM, Chandler CJ. Metabolic interactions of alcohol and folate. J Nutr 2002;132:2367S-72S.
72. Laufer EM, Hartman TJ, Baer DJ, Gunter EW, Dorgan JF, Campbell WS, et al. Effects of moderate alcohol consumption on folate and vitamin B(12) status in postmenopausal women. Eur J Clin Nutr 2004;58:1518-24.
73. Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G. Subgroup analyses in randomised controlled trials: Quantifying the risks of false-positives and false-negatives. Health Technol Assess 2001;5:1-6.
74. Christov K, Chew KL, Ljung BM, Waldman FM, Duarte LA, Goodson WH 3rd, et al. Proliferation of normal breast epithelial cells as shown by in vivo labeling with bromodeoxyuridine. Am J Pathol 1991;138:1371-7.
75. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LYC. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981-6.
76. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DEC. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2002;360:2047-8.
77. Quinlivan EP, Gregory JF. Effect of food fortifi cation on folic acid intake in the United States. Am J Clin Nutr 2003;77:221-5.
78. Lawrence JM, Petitti DB, Watkins M, Umekubo MA. Trends in serum folate after food fortification. Lancet 1999;354:915-6.
79. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 1991;338:131-7.
80. Weir HK, Thun MJ, Hankey BF, Ries LAG, Howe HL, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003;95:1276-99.
81. Kotsopoulos J, Sohn KJ, Martin R, Choi M, Renlund R, McKerlie C, et al. Dietary folate deficiency suppresses N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Carcinogenesis 2003;24:937-44.
82. Kotsopoulos J, Medline A, Renlund R, Sohn KJ, Martin R, Hwang SW, et al. Effects of dietary folate on the development and progression of mammary tumors in rats. Carcinogenesis 2005;26:1603-12.
83. Baggott JE, Vaughn WH, Juliana MM, Eto I, Krumdieck CL, Grubbs CJ. Effects of folate deficiency and supplementation on methylnitrosourea-induced rat mammary tumors. J Natl Cancer Inst 1992;84:1740-4.
84. Davey Smith G, Ebrahim S. Folate supplementation and cardiovascular disease. Lancet 2005;366:1679-81.
85. Clarke R, Armitage J. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost 2000;26:341-8.